Professional Documents
Culture Documents
1. Topics
2. Hepatitis
3. Alcoholic and NAFLD
4. Circulatory Disorders of the Liver
5. Tumors of the Liver
6. GIT Pharmacology
7. GIT Toxicology (Forensics)
GIT and Liver Topics
Anatomy:
● Overview: structure and function of GIT
● Overview of blood supply and venous drainage of hepato-biliary system & macroscopic &
microscopic structure of Liver
Physiology:
● Overview: secretory, digestive, and absorptive function of the GIT
● Role of diet and nutrition/lifestyle modification
Biochemistry:
● Overview of dietary carbohydrates and glycemic index
● Overview of dietary fats & lipids, in relation to rancidity & per oxidation
● Overview of dietary proteins & nitrogen balance
● Nutritional energy balance
● Overview of bio-molecular function
● Differentiate between pre-hepatic, hepatic & post-hepatic causes of jaundice
● Nutrition care plan development & nutrition toxicology
Pathology:
● Pathogenesis of gastritis and peptic ulcer
● Tutorial: histopathology of gastric diseases
● Malabsorption syndrome (Celiac disease)
● Inflammatory bowel diseases
● Infective agents of dysentery & diarrhea
● Tutorial: stool DR and culture
● Enterocolitis and ischemic colitis
● Tumors of stomach
● Tumors of small & large intestine
● Tutorial: histopathology of intestinal tumors
● General features of hepatic disease (patterns of hepatic injury, hepatic failure, jaundice &
cholestasis)
● Hepatitis
● Alcoholic & non-alcoholic (NASH)
● Tumors of liver
● Cirrhosis & portal hypertension & circulatory disorders of liver
● Pathology of gallbladder
● Non-neoplastic disorders of exocrine function of pancreas
Medicine:
● GERD, esophagitis, Barrett’s, hiatus hernia
● Diagnosis and management of upper GI bleeding
● Causes, clinical presentation and management of malabsorption syndrome/ Celiac
disease
● Irritable bowel syndrome
● Acute gastroenteritis
● Clinical presentation and outline of management of hepatitis B and C
● Management of acute hepatitis & fulminant hepatic failure
● Ascites and concept of SAAG, hepatic encephalopathy & hepato-renal syndrome
● Liver abscess & tumors
Surgery:
● Clinical presentation and surgical management of IBD
● Management of intestinal obstruction (small & large bowel) & paralytic ileus
● Management of acute abdomen & peritonitis
● Management of CA esophagus and achalasia
● Management of gall bladder cancer
● Cholelithiasis – Presentation, Sequalae & Management
● Management of acute & chronic pancreatitis
● Perianal abscess; fistula-in-ano & hemorrhoids
● Surgical management of CA colon
● Abdominal trauma (primary and secondary survey pertaining to abdomen)
● TB abdomen
● Ventral hernias workup and management
● Management of obstructive jaundice & pancreatic tumor
● Management of acute abdomen & peritonitis
Pharmacology:
● Tutorial: effect of drug on the intestine of rabbit – preparation of Ach solution
● Proton pump inhibitors and H2 receptor antagonists
● Mucosal protective & Rx of H.Pylori
● Tutorial: treatment of peptic ulcer
● Emetics and antiemetics
● General management of Diarrhea & IBS
● Drugs used in Amebiasis
● Drugs used in constipation
● Management of hepatitis
● Pharmacological treatment of hepatitis B and C
Forensic Medicine:
● Tutorial: non-metallic irritants
● Traumatology
● Regional injuries
● Tutorial: metallic irritants -- arsenic
● Head and spinal cord injuries (regional injuries)
● Neck, chest, face, heart, and lung injuries
● Metallic irritants -- mercury
● Road traffic accidents
● Thermal injuries
● Metallic irritants -- lead
● Hepatic poison -- alcohol
● Copper
● Environmental trauma
● Toxicology -- irrespirable gases
Community Medicine
● Demography
Clinical Postings:
● History taking
● History taking in a surgical patient
● Surgery: general and physical examination in a surgical patient
● Peds – examination of respiratory system
● Abdominal examination
● Surgery: history and examination of an ulcer
● Surgery: examination of a swelling/lump (skin)
● Surgery: sterilization and disinfection
● Examination of an inguinoscrotal swelling
Skill Lab:
● Abdominal examination
● NG tube intubation
Pediatrics:
● Acute & chronic diarrheas
● Causes of vomiting, regurgitation/dysphagia in children; GERD
● Pediatric surgery: congenital and acquired causes & management of constipation
● Storage and metabolic disorders; acute hepatic failure/hepatitis
● Biliary atresia/cholestatic jaundice
Radiology:
● Recognition of normal & abnormal GIT structures
● Recognition of normal & abnormal hepatobiliary structures
Hepatitis
• Hepatitis A is usually self-limited; vaccine is available
• Hepatitis B can cause:
o Acute hepatitis followed by recovery
o Non-progressive chronic hepatitis
o Progressive chronic hepatitis ending in cirrhosis
o Acute hepatic failure with massive liver necrosis (rare)
o Asymptomatic healthy carrier state
• Hep B is associated with hepatocellular carcinoma
• Vaccine against Hep B is present
• Age at the time of Hep B presentation is the best predictor for disease chronicity – the
younger the patient, the higher the chance of chronicity
• Hepatitis C RNA pol is low-fidelity, which gives rise to multiple genotypes. Within the
same person, closely related genetic variants of Hep C can exist; these are known as
quasispecies.
• In hep C, antibodies are formed against the E2 protein of the envelope. However, the
protein is encoded by the most variable region in the virus’ genome. This allows
emergent strains to escape antibodies, and this why there’s no vaccine for hepatitis C.
• Acute infection with hep C is often asymptomatic and missed. Chronic illness is the
hallmark of hepatitis C.
• Hepatitis C can induce insulin resistance, and is associated with metabolic syndrome.
• Hepatitis E is a zoonotic infection. Although it’s not related to chronic disease, chronic
disease can develop in immunocompromised (post-transplant or AIDS) patients.
• Hepatitis A, B, E, and D can cause fulminant hepatitis.
• The most common finding in symptomatic chronic hepatitis patients is fatigue.
• Morphology:
o Viral hepatitis morphology can mimic drug-induced and autoimmune hepatitis
morphology
o Acute and chronic hepatitis both invoke a lymphoplasmacytic infiltrate
o Acute hepatitis: portal inflammation is minimal – lobular hepatitis is common
(injury scattered throughout the lobule a.k.a spotty necrosis) – bridging necrosis
may occur in severe cases – hepatitis A infiltrate is especially rich in plasma cells.
o Chronic hepatitis: defining histological feature is a mononuclear portal infiltrate
– interface (between parenchyma and portal tract) hepatitis is seen – fibrosis of
portal tracts at first, and progression to cirrhosis later – ductular reactions are
seen – clinical assessment often requires biopsy
o Chronic Hepatitis B – ground-glass appearing cells – due to HBsAg filling the ER is
a diagnostic hallmark
o Chronic Hepatitis C – often should lymphoid aggregation and follicles and fatty
change of scattered hepatocytes
Alcoholic and Non-Alcoholic Fatty Liver
Disease
Alcoholic liver disease:
o All changes begin in acinus zone 3 (closest to the central vein)
o Hepatic steatosis: even after moderate intake, liver cells accumulate fat droplets
– completely reversible with abstinence
o Alcoholic steatohepatitis: fat accumulating causes hepatocytes to burst
(ballooning) and die – Mallory-Denk bodies visible; these are made of
intermediate filaments in complex with proteins like ubiquitin; non-specific (also
seen in NAFLD) – neutrophils infiltrate the liver and surround ballooned
hepatocytes – presents acutely after heaving drinking, symptoms are non-
specific but can be those of acute liver failure – hepatorenal syndrome may
follow
o Alcoholic steatofibrosis: activation of stellate cells – fibrosis begins at central
vein – scar spreads out in chicken wire fence pattern (groups of hepatocytes
surrounded by fibrosis) – eventually, nodules develop and cirrhosis sets in –
continued use of alcohol leads to more subdivision of established nodules, which
leads to micronodular or Laennec cirrhosis – patient can develop hepatocellular
carcinoma
o Causes of alcoholic liver damage:
▪ Increased lipid synthesis due to increased NADH from alcohol metabolism
▪ Acetaldehyde damages cells by causing lipid peroxidation
▪ Alcohol impairs liver metabolism of methionine, reducing glutathione
synthesis and oxidative damage
▪ Alcohol causes release of bacterial endotoxin from gut into portal
circulation, which damages the liver
Benign neoplasms:
o Cavernous hemangiomas – most common benign liver tumor – made of vascular
channels in a bed of CT
o Hepatocellular adenomas
▪ Derived from hepatocytes
▪ May rupture, which is a surgical emergency
▪ Associated with oral contraceptives and anabolic steroids
▪ Cessation to exposure to sex hormones can lead to full regression
▪ Three subtypes
• HNF1a inactivated adenomas – fatty with no risk of malignant
transformation
• B-catenin activated adenomas – very high risk of malignant
transformation – should be resected
• Inflammatory adenomas – small but definite risk of malignant
transformation – have areas of fibrotic stroma, mononuclear
inflammation, ductular reaction, and telangiectatic vessels (other
adenomas are mainly made of hepatocytes)
Malignant tumors:
o Hepatoblastoma – most common liver tumor of early childhood
o Hepatocellular carcinoma
▪ Chronic liver disease is the most common setting for its emergence
▪ Most important underlying factors – viral infections (Hep B, C) and toxins
(alcohol, aflatoxin)
▪ Metabolic diseases like hemochromatosis and metabolic syndrome also
increase the risk of HCC
▪ Most common mutations – activation of B-catenin and inactivation of p53
▪ Precursor lesions:
• Adenoma
• Large cell change
• Small cell change
• Dysplastic nodules – often detected in cirrhosis – can be low-
grade and high-grade – high-grade are the most important
primary pathway of HCC emergence in viral hepatitis and alcoholic
liver disease
▪ Morphology:
• May present grossly as:
o Unifocal mass
o Multifocal widely distributed nodules
o Diffuse infiltrative cancer
• Metastasizes via blood – lung is a common site
• Can invade the portal vein (portal HTN), IVC, or the right side of
the heart
• Fibrolamellar carcinoma – single, large tumor with fibrous bands
coursing through it – it’s a subtype of HCC
▪ Symptoms, diagnosis, and treatment
• Symptoms – ill-defined abdominal pain, malaise, fatigue,
hepatomegaly – cause hypoglycemia (high metabolic activity) and
erythrocytosis (produce EPO) – can cause Budd-Chiari syndrome
• Diagnosis – a-fetoprotein is raised but is an insensitive screening
test – most valuable tool for diagnosis is imaging – but remember,
the definitive diagnosis of cancer is made by biopsy
• Treatment – small tumors can be surgically removed with good
outcomes – radiofrequency ablation is used for local control of
large tumors – chemoembolization can also be used
o Cholangiocarcinoma
▪ Second most common primary malignant liver tumor after HCC
▪ Malignancy of biliary tree
▪ Risk factors:
• Liver flukes
• Chronic inflammation of bile ducts
• Hep B, C, and NAFLD
• Most are sporadic
▪ Can be intra- or extrahepatic
▪ Klatskin tumor – extra-hepatic cholangiocarcinoma at the junction of left
and right hepatic ducts
▪ Extra-hepatic tumors are small at the time of diagnosis because they
rapidly cause symptoms of obstruction – they arise as firm gray nodules
within the duct
▪ Cholangiocarcinoma is adenocarcinoma and produces mucin
o Metastasis
▪ More common than primary liver cancers
▪ Common sites where they come from are – colon, breast, lung, and
pancreas
o Hepatic angiosarcoma
▪ Associated with PVC and arsenic
GIT Pharmacology
The vomiting reflex:
• Vomiting center is located in the medulla oblongata.
• Vomiting center contains muscarinic receptors -- stimulation triggers the emetic reflex.
• CTZ (chemoreceptor trigger zone) -- also located near the medulla.
o gets triggered by chemicals
o contains -- D2 and 5 HT3 receptors
o when stimulated, stimulates the vomiting center
o is outside the BBB
• Motion sickness:
o Initiated by the inner ear
o Vestibulocochlear nerve brings signals to the vestibular nuclei
o Vestibular nuclei contain H1 and muscarinic receptors
o Vestibular nuclei pass signals to CTZ, which stimulates the vomiting center
• Vomiting can also result due to signals from higher brain centers -- cerebrum
o Emotional factors
o Pain
o Repulsive sight or smell
o Signals stimulate the vomiting center
• Vomiting can also occur from things happening in the stomach
o Stomach has EC cells -- release serotonin in response to cytotoxic agents
o Stimulates 5 HT 3 receptors on vagus nerve
o Information goes to the vomiting center
• Vomiting reflex (caused by signals from the vomiting center):
o LES relaxes
o Diaphragm and abdominal muscles contract
o Intra-abdominal pressure rises
o Autonomic changes -- tachycardia, increased salivation and peristalsis
o Epiglottis closes
o Vomiting happens!
Antiemetics
• Anti-emetics target the following receptors:
o Area postrema (CTZ)– 5HT3, D2, M1
o Stomach/small intestine – 5HT3
o Solitary tract nucleus – 5HT3, D2, M1, H1
o Cerebellum – H1, M1
• Give anti-emetics to treat vomiting caused by:
o Chemotherapy
o Post-irradiation
o Surgery
o Pregnancy
o Motion sickness
• Weak tea, carbonated drinks, Gatorade and pedialyte (children) can also treat vomiting
• 8 categories of anti-emetics:
o Dopamine antagonists (phenothiazines, butyrophenones, benzamides,
benzimidazole)
o Anti-histamines
o Anti-cholinergics (scopolamine aka Hyoscine)
o Benzodiazepines
o Serotonin antagonists (ondansetron)
o Glucocorticoids
o Cannabinoids
o Miscellaneous
• Phenothiazines – prototype is chloropromazine, can produce symptoms like
hypotension, sedation, and Parkinsonism (extrapyramidal syndrome), which limits their
use.
• Dopamine antagonists are not effective in motion sickness induced vomiting.
• Ondansetron is a selective 5-HT3 blocker, which blocks 5-HT released by EC cells in the
gut after administration of cytotoxic drugs. Also works in the CTZ.
• Cannabinoids are moderately effective against emetogenic chemotherapy, and
probably act on vomiting center. Hallucinations, disorientation, and vertigo are side
effects. Their use is limit to patients refractory or intolerant to other anti-emetic agents.
• H1 receptor antagonists and anticholinergics are mainly used for prevention of motion
sickness. Hyoscine aka scopolamine (anti-muscarinic) is the drug of choice, and it blocks
conduction in vestibular apparatus. Anti-motion sickness drugs should be taken 0.5 to 1
hour before the journey, once sickness starts, it is difficult to control. H1 receptor
antagonists are also used in suppressing chemo-induced vomiting in addition to D2
antagonists and help reduce their extra-pyramidal side effects. Anti-muscarinic drugs
reduce side effects of metochlopramide. Main side effects include dryness of mouth,
urine retention, and mydriasis.
• Benzodiazepines have low anti-emetic effects and prevent anticipatory emesis which
accompanies chemotherapy.
• Dexamethasone (glucocorticoid) has moderate anti-emetic effects and probably works
by reducing peritumoral inflammation and PG production. Should be avoided in
psychotic and diabetic patients.
• Vomiting in pregnancy sometimes results from pyridoxine deficiency, so pyridoxine (B6)
should be given.
Anti-diarrheals
• According to WHO, diarrhea = 3 or more loose or liquid stools per day
• Acute diarrhea has a sudden onset, lasts from3 days to 2 weeks and is self-limiting. Can
be bacterial, viral, drug-induced, nutritional, protozoal.
• Chronic diarrhea lasts for more than 3 weeks, and is associated with other symptoms
like nausea, vomiting, loss of appetite, and weakness. Causes include tumors, diabetes,
Addison’s disease, hyperthyroidism, irritable bowel syndrome.
• Oral rehydration therapy is immediately started after onset of diarrhea until diarrhea
resolves, often spontaneously.
• ORS – NaCl, KCl, Sodium citrate, Glucose dissolved in one liter of water.
• Glucose is included in ORS because it facilitates sodium absorption in the gut via the
SGLT1 symporter.
• Citrate/bicarbonate corrects acidosis caused by loss of alkali in stool.
• ORS is isotonic.
• 5 categories:
o Adsorbents
o Anticholinergics
o Intestinal flora modifiers
o Opiates
o Opiate-related agents
• Adsorbents coat GI walls and bind to causative agents or toxins which are then
eliminated through stool. E.g. bismuth subsalicylate, activated charcoal. Adsorbents are
not used for more than 2 days. Side effects: increased bleeding time, heating loss, blue
gums.
• Anticholinergics slow peristalsis, e.g. belladonna alkaloids, atropine. Contraindicated in
patients with diarrhea caused by organisms which penetrate the GI mucosa e.g.
salmonella.
• Intestinal flora modifiers e.g. cultures of lactobacillus work by production of lactic acid
and favor establishment of aciduric bacteria and suppress growth of diarrhea-causing
bacteria.
• Opiates decrease bowel motility e.g. codeine.
• Opiate related agents include loperamide and diphenoxylate and decrease GI motility.
Not used on children under 2 years of age and with those bacteria which penetrate GI
mucosa e.g. bacterial entercolitis caused by salmonella and shigella, and with
pseudomembranous colitis associated with broad-spectrum antibiotic use.
• Octreotide: inhibits many GIT hormones, reduces intestinal fluid secretion and slows GI
motility. It also induces a reduction of portal and splanchnic blood flow.
Anti-acids
• Weak bases which react with HCl. They increase pH and therefore decrease pepsin
activity. Pepsin doesn’t work at a pH greater than 4.
• More effective in duodenal ulcers than in gastric ulcers
• H2 antagonists and PPIs are preferred over antacids in GERD
• Magnesium and aluminum antacids reduce bioavailability of iron, tetracyclines,
benzodiazepines, phenothiazines, NSAIDs, ranitidine, phenytoin, and vitamin A
• Calcium antacids reduce absorption of tetracyclines
• Antacids increase elimination of phenobarbitone and salicylates and decrease
elimination of amphetamine, ephedrine, quinidine, mecamylamine
• Non-systemic antacids
o Make a protective film over gastric lining
o Water insoluble and not absorbable
o In stomach, cations react with HCl to form chlorides which react with
bicarbonates in small intestines and inhibit their absorption.
▪ Aluminum Hydroxide
● Slow acting, and slow down gastric emptying
● Stimulate mucus production
● Prevent phosphate absorption
● Constipation is main side-effect, which is overcome by adding
magnesium antacids. Megaldrate = complex hydroxymagnesium
aluminate
▪ Calcium Carbonate
● Quick acting
● Rebound hyper-secretion present
● Decreases phosphate absorption
● Side-effects include belching, flatulence, and nausea due to CO2
release and milk-alkali syndrome
▪ Magnesium Trisilicate
● Slow acting, but prolonged action
● Becomes gelatinous and forms a covering over ulcers
● Side-effects include mild diarrhea and CNS depression in renal
failure patients
▪ Magnesium Hydroxide
● Quick acting
● Has osmotic effects so causes diarrhea
• Systemic antacids
o Soluble and easily absorbable
o Decrease acidity but cause systemic alkalosis due to bicarbonate absorption
▪ Sodium Bicarbonate
● Rebound hyper-secretion
● May produce milk-alkali syndrome in large doses
● CO2 release causes side-effects like distention which is harmful
for patients approaching perforation of an ulcer.
Peptic Ulcer and GERD Drugs
• Triple therapy used to treat H.pylori induced ulcers and includes:
o A proton-pump inhibitor (PPI)
o Amoxicillin
o Clarithromycin
• H2-receptor antagonists – competitive blockers
o Histamine normally stimulates Gs protein in parietal cells which then activates
protein kinase which then activates H/K pump. ACh and gastrin increase calcium
levels to activate protein kinase. PGE2 stimulates Gi protein.
o The four drugs are cimetidine, ranitidine, famotidine, and nizatidine.
o Cimetidine was the first H2 antagonist but its use is limited due to its side-
effects.
o Use of these agents has decreased as PPIs have taken over.
o Treat H.pylori associated ulcers well, but NSAID induced ulcers should be treated
using PPIs.
o Can also be used to treat acute stress ulcers but again, PPIs are preferred.
o GERD is treated with PPIs because:
▪ H2 antagonists work in only 50% of patients with GERD
▪ H2 antagonists need at least 45 minutes for their effects
▪ Antacids work only temporarily
o Side effects:
▪ Only cimetidine has anti-androgenic effects; it causes gynecomastia and
galactorrhea
▪ Cimetidine inhibits cytochrome P450 enzymes thereby interferes with
metabolism of drugs like warfarin, phentoyin, and clopidogrel.
▪ All H2 antagonists reduce efficacy of drugs which require an acidic
environment for absorption.
• PPIs
o Bind to H/K pumps
o All have “prazoles” at the end of their names
o Omeprazole, esomeprazole, and lansoprazole are available over-the-counter for
treatment of GERD
o Are taken as pro-drugs with an acid-resistant covering, are absorbed in the
alkaline duodenum and then are taken to parietal cells where they are converted
to active drugs which form a stable covalent bond with H/K pumps. (Since the
bond is stable, PPIs have a long duration of action.)
o Superior to H2 antagonists in acid suppression and ulcer treatment
o PPIs require active proton pumps to work, therefore, if an H2 antagonist is being
taken alongside a PPI, it should be taken well after the PPI.
o All PPIs are effective orally, and should be taken 30 to 60 minutes before the
largest meal of the day.
o Side effects:
▪ Omeprazole and esomeprazole inhibit CYP2C19 and reduce the
effectiveness of clopidogrel
▪ If used for more than 1 year, fractures are a risk
▪ Prolonged acid suppression may reduce absorption of vitamin B12
▪ Calcium carbonate absorption is impaired with increased gastric pH, so
supplementation with calcium citrate given
▪ Diarrhea and Clostridium difficile colitis (some bug which also causes
diarrhea)
• Prostaglandins
o PGE normally inhibits gastric acid production and stimulates mucus and
bicarbonate production.
o Misoprostol (PGE1 analog) is used to treat NSAID induced ulcers.
o Misoprostol should not be given in pregnancy since it can cause uterine
contractions and miscarriage.
o PPIs are still preferred for NSAID ulcers.
Phosphorus
• White (crystalline) phosphorus (turns yellow) and is highly poisonous. Gives off fumes that glow
with a pale-yellow color – phosphorescence. Red (amorphous) phossy is inert unless
contaminated with white.
• MOA – protoplasmic poison – diminishes cellular metabolism (necrobiosis).
• Causes increased fat deposition in the liver and decreased glycogen deposition. Also causes
necrosis of the bone.
• Acute poisoning sx – burning sensation; garlic taste in the mouth; vomited matter and diarrhea
are luminous in the dark. Jaundice and distension of the abdomen due to liver necrobiosis. In
later stages, liver shrinks (acute yellow atrophy).
• Tx – oily and fatty substances contraindicated (increase phossy absorption). Wash stomach with
potassium permanganate, which acts as a chemical antidote.
• PM findings – stomach and bowel contents may be luminous and body might smell of garlic. If
death is delayed, fatty degeneration and hemorrhages are seen internally. Subendocardial
hemorrhages in the left ventricle are common.
• Preserve viscera in saturated solution of salt – phossy can be detected in putrefied bodies too.
• Chronic poisoning is characterized by phossy jaw – osteomyelitis of mandible with multiple
sinuses discharging foul smelling pus.
Iodine
Bromide
• Causes poisoning if finely divided and ingested, inhaled, or rubbed into skin.
• MOA – combines with SH groups.
• Acute poisoning sx – highest concentration found in kidney; a metallic taste is felt; burning
sensation and pain in the abdomen; nausea and vomiting; collapse; urine contains blood and
albumin.
• Tx – if no vomiting, emetics/lavage with sodium formaldehyde sulphoxylate; egg albumin can be
given; BAL for removal from tissues; cuprimine (penicillamine derivative) is effective.
• PM appearances are those of corrosive poisoning – mouth has diffuse greyish white escharotic
appearance.
• Chronic poisoning aka hydragyrism
o Excessive salivation
o Loosening of teeth
o Inflamed gums
o Blue-black line on gums
o Ulcers near nails/knuckles
o Nephritis
o Mercuria lentis – discoloration of eye lens capsule is an early sx
o Erethism – personality change – shyness, irritability; hatter’s shake (a coarse intentional
tremor that affects the hands, arms, and tongue).
o Tx – belladonna for salivation; IM BAL; sodium hyposulphite for dermatitis.
Lead
Copper
• MOA – leads to the generation of formaldehyde and formic acid, which mediate damage.
Formic acid can lead to severe metabolic acidosis.
• Signs – intestinal contraction is diagnostic – intestines look like a thick pipe with a very narrow
lumen.
• Tx – stomach wash with sodium bicarb only within 2-4 hours of ingestion; ethanol is the
antidote; sodium bicarb for acidosis.
• Preserve viscera in saturated solution of salt.
• Poisoning usually occurs when an alcoholic cant find alcohol and resorts to methanol, which is
found in antifreeze, paint removers, and varnishes.